Multidisciplinary Association for Psychedelic Studies (MAPS)

Are you involved in psychedelic medicine for end-of-life care? We need your insights to shape this essential work. End of Life Psychedelic Care, in partnership with the University of Chicago, has launched the Psychedelic Death Worker Narrative Survey. This in-depth survey aims to capture the knowledge and experiences of practitioners like you. The findings will help build best practices, identify challenges, and understand the impact on relationships between clients, families, and caregivers. 🗓 Deadline: Nov 8, 11:59pm PT 🕒 Estimated time: 20-30 mins 🔗Click here to participate: https://lnkd.in/gwRKKFSY ⭐️Eligibility Criteria: -Must be at least 18 years of age -Facilitates ketamine, psilocybin, or other psychedelic medicine sessions with clients confronting life-limiting or life-threatening diagnosis. If you have any questions, please send an email to christine@eolpc.org

After reflecting on the recent election results, MAPS remains optimistic about the future of federal support for psychedelic research through agencies like the Veterans Administration and the National Institutes of Health. We urge the incoming administration to engage with diverse stakeholders—from federal and state agencies to local community advocates—to shape policies that genuinely serve the public interest and uphold rigorous standards for safety and ethics. Our commitment to fostering understanding, reducing stigma, ending the failed drug war, and advocating for equitable, safe access to psychedelic therapies remains steadfast. We look forward to collaborating with advocates nationwide to responsibly harness the transformative potential of psychedelics for the well-being of individuals and society at large. P.S. Regardless of your position on Question 4 or your political orientation, elections can be stressful. If you are struggling, you can find resources for support using the link below https://lnkd.in/g5miRSFf

On this election day, MAPS is taking a step back to focus on civic duty, recognizing the power of voting to shape our collective future. Every vote cast is a chance to influence the path forward, impacting policies and creating opportunities for positive change across our communities. Join us in making your voice heard. Head to the polls and be part of shaping tomorrow.

In a recent interview with Students for Sensible Drug Policy (SSDP), Rick Doblin reminded us of how essential it is to show up and vote. Voting is more than a single action; it’s a step toward creating the future we want to see. Each vote amplifies our voice and builds the foundation for change on the issues that matter most. With the election just days away, now’s the moment to ensure your voice is part of this close race. It's not too late! Visit the link below to find a polling location place near you✅ Vote.gov

In this week's MAPS Bulletin, cognitive neuroscientist Alexandre Lehmann, Ph.D., takes us on a journey through the unique connection between music and psychedelics. From tribal rhythms in ancient ceremonies to MDMA-assisted therapy today, music has long served as a guide in altered states, helping individuals explore inner realms of healing and transformation. As we explore music’s potential to amplify psychedelics’ benefits, Lehmann envisions a future where these elements foster personal and communal healing. Today’s sessions and gatherings might draw on music’s power to deepen connection, reduce isolation, and rekindle a sense of belonging. Read the full article using the link below, and let us know your thoughts!💭 https://lnkd.in/g5GB-Na7

In case you missed it, featured in mg Magazine, Vice President Kamala Harris has voiced her commitment to prioritize federal marijuana legalization, potentially marking a significant change in U.S. drug policy. Responding to this call for reform, MAPS' founder Rick Doblin emphasizes the critical need to address outdated policies that have disproportionately affected marginalized communities and stalled groundbreaking research. MAPS is prepared to support efforts that drive safe, therapeutic applications of cannabis and psychedelics, aiming to shift drug policy toward one rooted in science, public health, and human rights. Read the full article: https://lnkd.in/gvRu_Beg

Join Rick Doblin and over 20 other influential leaders and visionaries at the Spirit Plant Medicine Conference, now in its 13th year, happening in Vancouver, BC, from November 1-3! For over a decade, SPMC has united voices from across the world, including Indigenous leaders, therapists, activists, and more, who share a belief in the transformative power of psychedelics. These allies bridge ancient wisdom and modern science. Learn more and secure your spot through the link below—in-person and online. https://lnkd.in/gHD6BpPE

Could Massachusetts’ Question 4 initiative be a turning point in ending the failed policies of the drug war? In an interview with Students for Sensible Drug Policy (SSDP)’s Gina Giorgio, Rick Doblin shares his perspective on how this citizen-led ballot measure is part of a broader cultural shift. Rick emphasizes that Question 4 is not just about local policy—it’s a crucial step in a movement to end the damaging legacy of drug prohibition. He highlights how the U.S., once a major force in spreading strict prohibitionist policies worldwide, now has the chance to lead a reversal of the failed drug war. As more states pursue drug policy reform, how could this movement create a ripple effect that influences the rest of the world? Click the link below to: ✅ Check your voter registration (Today is the last day to do so in Massachusetts!) ✅ Cast your vote ✅ Make an impact on psychedelic policy reform! vote.gov

🚨BIG NEWS!🚨 Politico reported that Dr. Shereef Elnahal, Undersecretary for Health at the Department of Veterans Affairs, said the VA is willing to consider supporting Lykos Therapeutics in funding an additional Phase III trial for their psychedelic-assisted therapy aimed at treating PTSD. This follows the FDA’s rejection of Lykos' initial application, requiring more data on the treatment’s safety and effectiveness. Despite setbacks, the VA's openness to support could be a game-changer, reflecting a renewed focus on exploring innovative solutions for veterans' mental health. https://lnkd.in/gixhm3cr

As Missouri looks to create a regulated psilocybin access program and fund psychedelic research through opioid settlement funds, there are increasing opportunities to join advocacy for decriminalization and broader legal psychedelic access. Join advocates from across the state on October 26th in St. Louis and November 9th in Kansas City for a series of insightful talks and discussions. Featuring presentations on psychedelic research by Dr. Josh Siegel of NYU Langone, panels covering therapy, facilitation, and policy opportunities at both state and federal levels, plus a keynote address on ibogaine research by Bryan Hubbard, former chair of the Kentucky Opioid Abatement Commission. The evening will conclude with a dinner benefiting nonprofits such as the Humble Warrior Wellness Center and Psychedelic STL. Learn more and register: https://lnkd.in/gf9KhW_y